U.S. flag

An official website of the United States government

NM_020944.3(GBA2):c.2506-2A>G AND Hereditary spastic paraplegia 46

Germline classification:
Likely pathogenic (1 submission)
Last evaluated:
Sep 28, 2022
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV002465072.3

Allele description [Variation Report for NM_020944.3(GBA2):c.2506-2A>G]

NM_020944.3(GBA2):c.2506-2A>G

Gene:
GBA2:glucosylceramidase beta 2 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
9p13.3
Genomic location:
Preferred name:
NM_020944.3(GBA2):c.2506-2A>G
HGVS:
  • NC_000009.12:g.35737449T>C
  • NG_033899.1:g.16780A>G
  • NG_046983.1:g.10130T>C
  • NM_001330660.2:c.*27A>G
  • NM_020944.3:c.2506-2A>GMANE SELECT
  • NC_000009.11:g.35737446T>C
Molecular consequence:
  • NM_001330660.2:c.*27A>G - 3 prime UTR variant - [Sequence Ontology: SO:0001624]
  • NM_020944.3:c.2506-2A>G - splice acceptor variant - [Sequence Ontology: SO:0001574]
Observations:
1

Condition(s)

Name:
Hereditary spastic paraplegia 46
Synonyms:
Spastic paraplegia 46, autosomal recessive
Identifiers:
MONDO: MONDO:0013737; MedGen: C2828721; Orphanet: 320391; OMIM: 614409

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV002759467Diagnostics Services (NGS), CSIR - Centre For Cellular And Molecular Biology
criteria provided, single submitter

(ACMG Guidelines, 2015)
Likely pathogenic
(Sep 28, 2022)
unknownclinical testing

PubMed (1)
[See all records that cite this PMID]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedunknownyes11not providednot providednot providedclinical testing

Citations

PubMed

Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.

Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, Voelkerding K, Rehm HL; ACMG Laboratory Quality Assurance Committee.

Genet Med. 2015 May;17(5):405-24. doi: 10.1038/gim.2015.30. Epub 2015 Mar 5.

PubMed [citation]
PMID:
25741868
PMCID:
PMC4544753

Details of each submission

From Diagnostics Services (NGS), CSIR - Centre For Cellular And Molecular Biology, SCV002759467.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not provided1not providednot providedclinical testing PubMed (1)

Description

The c.2506-2A>G is not present in publicly available population databases like 1000 Genomes, EVS, ExAC, gnomAD, Indian Exome Database or our in-house exome database. The variant has neither been published in literature nor reported to clinical databases like ClinVar, Human Genome Mutation Database (HGMD) and/or OMIM, in any affected individuals. In silico pathogenicity programs like MutationTaster2, CADD, Varsome, HSF3.1 etc. predicted this variant to be likely deleterious by causing splicing aberration, however these predictions were not confirmed by any published functional/translational studies.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1unknownyesnot providednot providednot provided1not provided1not provided

Last Updated: Jun 24, 2023